Uematsu et al. have reported that MRI findings including a smooth mass margin, rim enhancement, and very high signal intensity on T2-weighted imaging were significantly associated with triple-negative breast cancers compared to ER-positive, PR-positive, and HER2-negative cancers (Uematsu et al. 2009). This evidence concerns the gene ERBB2 and cancer.